Munich, Germany – In the face of tightening capital markets, evolving regulatory landscapes, and strategic dealmaking, a new industry event is set to provide guidance for biopharma professionals. BioPharma Deals: The Survival Series, a strategic conference designed for business development, licensing, and investment leaders, will take place on 24-25 November, 2025 in Munich, Germany.
